The effect of non-ionic X-ray contrast media on glial cells in vitro
By Aardal, N.P. - Andersen, K.J. - Christensen, E.I. - Vik, H.
| Record number: | 2928304 |
|---|---|
| Category: | animal use alternatives - cell lines - neuroglia - rats - viability - anatomy and morphology - lysosomes - enzyme activity |
The rat glial cell line C6 has been used to assess the toxicity of two different iodine-based X-ray contrast media: the non-ionic dimer iodixanol and the non-ionic monomer iohexol. The cells were exposed to increasing concentrations (0-75mg iodine/ml) during exponential growth (up to eight days). A dose-dependent inhibition of cell growth was observed when iohexol was added to the culture medium, but not when iodixanol was added. While iohexol had a profound, long lasting effect on cell viability, iodixanol, after an initial adverse impact, had no effect. Iohexol and iodixanol both caused increased lysosomal peptidase activity, as shown for dipeptidyl peptidase, but had no effect on other lysosomal enzymes, such as acid beta-galactosidase. Electron microscopy revealed no changes in the cellular ultrastructure after exposure to iodixanol. In contrast, there was extensive vacuolisation in the cells exposed to iohexol, including a significantly increased number of autophagocytic vacuoles. It would appear that iodixanol has only minor effects on glial cells in culture, compared to those induced by iohexol.
Issued: May/June 1994
Journal Title: Alternatives to laboratory animals
ISSN: 0261-1929
Volume issue: 22 v. 3 no.
Pages: 193 - 200
Notes:
Paper presented at the Eleventh Congress on In Vitro Toxicology of the Scandinavian Society for Cell Toxicology, Sept. 9-12, 1993, Denmark.
AGRICOLA identifier: IND20499473
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.